Back
Lifestyle

Anxiety Medication Use Increases in U.S. Amidst Public and Medical Debate

Generated on: Last updated: 3 sources
View source

Rise in Anxiety Medication Use: A National Trend

The proportion of American adults using anxiety medications rose from 11.7% in 2019 to 14.3% in 2024. This increase represents an additional 8 million individuals, bringing the total to approximately 38 million Americans.

Largely observed during the COVID-19 pandemic, this notable rise has prompted widespread discussions regarding medication efficacy, safety, and underlying societal factors. The increase was most pronounced among young adults, individuals with a college degree, and those identifying as LGBTQ+.

Overview of Medication Use Trends

Between 2019 and 2024, the use of anxiety medications among adults aged 18 to 34 significantly increased from 8.8% to 14.6%.

Women are also more frequently prescribed anxiety medication than men. Researchers attribute this disparity to higher reported anxiety levels in women and increased recognition of anxiety symptoms by healthcare professionals.

Factors Contributing to Increased Use

Several key factors have been identified as potential contributors to the rise in anxiety medication use:

  • Societal Changes: Increased social media use, greater social isolation, and heightened economic uncertainty are frequently cited as contributing elements. Sociologist Jason Schnittker also points to broader trends such as growing income inequality, increased isolation replacing traditional social and religious activities, and a general rise in suspicion among individuals as factors contributing to the prevalence of anxiety across generations.

  • Accessibility: Easier access to prescriptions through primary care physicians and the rapid expansion of telehealth appointments have made medications more readily available to a wider population.

  • Reduced Stigma: Discussions about mental health, particularly amplified on social media, are reported to have significantly contributed to reduced stigma. This cultural shift is encouraging younger populations, in particular, to seek assistance for their mental health concerns.

Debate Surrounding Selective Serotonin Reuptake Inhibitors (SSRIs)

The increased use of selective serotonin reuptake inhibitors (SSRIs), a class of antidepressants that includes common medications like Prozac, Zoloft, and Lexapro, has become a significant subject of public debate.

Criticisms of SSRIs

Some groups, notably supporters of the "Make America Healthy Again" (MAHA) movement, have asserted that SSRIs are harmful.

Officials have also voiced significant concerns:

Health and Human Services Secretary Robert F. Kennedy Jr. has expressed concerns regarding the difficulty of discontinuing SSRIs, stating that some individuals, including family members, found quitting them "more challenging than quitting heroin." Kennedy Jr.'s agency is reportedly investigating a potential correlation between psychiatric medications and violent behavior, such as school shootings.
Food and Drug Administration Commissioner Marty Makary has suggested a possible link between SSRI use during pregnancy and adverse birth outcomes.

Medical Community Perspectives

In contrast, doctors and researchers within the medical community, including Patrick Kelly of the Southern California Psychiatric Society and psychiatrist Emily Wood, assert that SSRIs are front-line treatments for many anxiety disorders, including generalized anxiety disorder and panic disorder. They firmly state that claims of SSRI addiction are not supported by evidence and that the medications are safe for extended use.

  • Efficacy and Side Effects: Studies indicate that over half of individuals with generalized anxiety disorder using an SSRI experienced at least a 50% reduction in symptoms. Approximately 1 in 12 participants discontinued SSRI use due to side effects, which can include upset stomach, brain fog, fatigue, and reduced libido. However, medical professionals note that for many users, these side effects are mild and manageable, with the benefits of treating chronic anxiety often outweighing the drawbacks. SSRIs are considered most effective when combined with appropriate therapy techniques.

  • Pregnancy Considerations: Medical professionals state that risks of SSRI use during pregnancy are low. They emphasize that these low risks contrast sharply with the increased risks to both mother and baby from untreated maternal depression.

Other Treatment Approaches for Anxiety

Beyond pharmacological interventions like SSRIs, various other effective approaches are utilized for managing anxiety:

  • Lifestyle Interventions: Supporters of the MAHA movement suggest that poor dietary choices and sedentary lifestyles contribute significantly to mental health issues, advocating for reduced consumption of ultraprocessed foods and increased exercise. Psychiatrists concur, noting that a healthy diet and regular exercise can serve as valuable adjunctive therapies for anxiety and depression.

  • Therapy: Talk therapy, particularly cognitive behavioral therapy (CBT), is widely recommended as a primary treatment for managing anxiety disorders. Mental health counseling also saw a substantial increase in use from 2019 to 2024, partly due to the significant expansion of teletherapy services.

  • Other Medications:

    • Benzodiazepines (e.g., Xanax): While effective for short-term acute anxiety relief, these medications carry a significant risk of addiction and require careful monitoring. They are generally not recommended for long-term use.
    • Beta-blockers (e.g., Propranolol): Sometimes prescribed off-label to manage physical symptoms of anxiety, such as a racing heart, beta-blockers are considered non-addictive and generally safe. Potential side effects can include dizziness and fatigue.